Integer Holdings Corp. (ITGR)
84.10
-0.26
(-0.31%)
USD |
NYSE |
Mar 20, 16:00
84.18
+0.08
(+0.10%)
After-Hours: 20:00
Integer Holdings Research and Development Expense (Quarterly) : 10.11M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 22.28M |
| QuidelOrtho Corp. | 45.80M |
| Abbott Laboratories | 721.00M |
| Plus Therapeutics, Inc. | 2.941M |
| Molina Healthcare, Inc. | -- |